Newsletters
- All
- Incentives
- Jobs
- Media & Graphics
- PK & PK-PD
- R&D Insight
- Wonkish
- Y2017
- Y2018
- Y2019
- Y2020
- Y2021
- All
- Incentives
- Jobs
- Media & Graphics
- PK & PK-PD
- R&D Insight
- Wonkish
- Y2017
- Y2018
- Y2019
- Y2020
- Y2021
Superb PBS Newshour segment on agricultural use of antibiotics + McKeena’s Big Chicken book
Dear All: I wrote a few weeks ago about the Stopping Superbugs series from PBS Newshour. PBS has since then added some superb new …
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
Dear All: “Good decisions come from experience, and experience comes from bad decisions … and paying attention.” You’ve probably heard …
High-resolution (effectively 3-D) drug concentration measurements in tissues
Dear All: I’m really not trying to flood your inbox with email, but when ideas surface I do like to …
Real-time continuous in vivo drug monitoring
Dear All: I recently became aware of a technology for real-time continuous in vivo monitoring of drug levels that I …
FDA Grand Rounds: The comprehensive in vitro proarrhythmia assay (CiPA) initiative
Dear All: Per an email received today, there will be an FDA Grand Rounds webcast on 14 Sep 2017 (noon-1p …
UK-China AMR Collaboration Competition
Dear All: It is great to see that the UK Department of Health (DH) and the Chinese Ministry of Science and …
Pull incentives for antibiotics: Duke-Margolis PAVE policy paper and PBS Newshour segments
Dear All: We can’t say it too often … our current approach to buying antibiotics is broken in that it …
Final FDA Unmet Need Guidance!
Dear All: Just out in the last 24h is the announcement that FDA’s 2013 Unmet Need Guidance has now been released …
Using Real-World Evidence: FDA Workshop on 13 Sep 2017
Dear All: There is a newly announced FDA workshop on 13 Sep on using real-world evidence. Here is the link and I’ve …
PBS FRONTLINE: Hunting the Nightmare Bacteria
Dear All: Frontline will today broadcast an updated version of the excellent Hunting the Nightmare Bacteria show that first broadcast in 2013. Here’s …
Powered by CARB-X: Portfolio expansion announced today!
Dear All: CARB-X has today announced funding of 7 more companies, bringing the total funded portfolio to 17 potential new therapies (or preventatives) and …
Workshop on TB drugs: Lessons for the antibacterial community
Dear All: I listened with interest to the 19 July 2017 FDA Workshop entitled “Development of New Tuberculosis Treatment Regimens– …
G20 declaration – Statements about action on AMR
Dear All: The G20 have released a declaration in which they specifically discuss their intent around AMR. See below a …
Lancet ID Commentary to the G20 on behalf of the DRIVE-AB Steering Committee
I am pleased to say that a commentary to the G20 on behalf of the DRIVE-AB Steering Committee has now …
Developing systemic & inhaled antibiotics for lung infections
Dear All: I missed it personally, but by all reports the session on 3 June 2017 at ASM Microbe entitled …
New European Action Plan on AMR
Dear All: An updated European One Health Action Plan on AMR was released today. See links and text excerpts below …
Delafloxacin approval / Good example of a modern label
Dear All: FDA’s approval of delafloxacin (BAXDELA) was announced on 20 June 2017 and the label can be found here. In …
FNIH’s submission to the HABP/VABP docket
Dear All: After a multi-year gestation period (my notes on this project go back to 2012!!), a comment on the …
NIAID workshop: What is a robust PK-PD package?
Dear All: The ~150 of us who gathered in Washington yesterday and today for the NIAID’s PK-PD workshop enjoyed a …
Assessing antibiotic value: Two papers on antibiotic-specific gaps in traditional Health Technology Assessments
Dear All: Among various paradoxes that surround antibiotic development, the challenge for health technology assessment (HTA) is often implied but …
